近期，《NeuroMarkers》 (《神经标志物（英文）》)杂志上发表的5篇文章为我们带来了全新的视角和研究成果。这些研究涵盖生物标志物的发现、验证及其潜在的临床价值，让我们看到了阿尔茨海默病诊疗新的曙光。

With a new raise provided by Flagship Pioneering, the new company is aiming to find “the silent window” before disease symptoms set in.

Flagship Pioneering has unveiled a new start-up that aims to find, then drug, targets that are specific to different states ...

Dementia biomarkers -- phosphorylated tau (P-tau181), neurofilament light (NfL), and glial fibrillary acidic protein (GFAP) -- are associated with age, sex, and apolipoprotein E (APOE) ε4 status.

Alzheimer’s disease is commonly thought of as an older person’s illness. But new research from Columbia University and the ...

ESTHER study found that non-modifiable factors like age, sex, and APOE ε4 status significantly influence blood biomarker ...

Scientists see several important uses for staging. For example, it can steer people more precisely to appropriate treatments.

Veravas, a leader in clinical diagnostics, today announced the general commercial availability of VeraBINDtm Tau, the first blood-based test designed to aid in the detection of Alzheimer's disease (AD ...

ARUP Laboratories has introduced a blood test for phosphorylated tau 217 (pTau 217) to aid in diagnosing the pathology of ...

A new study reveals that cognitive changes tied to Alzheimer's risk factors begin far earlier in life than previously thought ...

How age, sex, genes, and menopause affect dementia biomarkers, aiding future blood test development for Alzheimer’s and other ...

Mayo Clinic researchers are studying why some Alzheimer's patients decline rapidly, aiming to find causes, biomarkers, and ...